Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women

被引:7
作者
Richardson, MA
Reilly, MA
Read, LL
Flynn, CJ
Suckow, RF
Maher, TJ
Sziraki, I
机构
[1] Nathan S Kline Inst Psychiat Res, Movement Disorders Div, Orangeburg, NY 10962 USA
[2] NYU, Med Ctr, Dept Psychiat, New York, NY 10016 USA
[3] Nathan S Kline Inst Psychiat Res, Div Neurochem, Orangeburg, NY 10962 USA
[4] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[5] Nathan S Kline Inst Psychiat Res, Psychopharmacol Div, Orangeburg, NY 10962 USA
[6] Massachusetts Coll Pharm & Allied Hlth Sci, Div Pharmaceut Sci, Boston, MA 02115 USA
[7] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA
[8] Inst Drug Res, Div Biochem, Budapest, Hungary
关键词
amine neurotransmitter supersensitivity; blood-brain barrier transport; gastric emptying; hepatic clearance; kinetics; large neutral amino acid; movement disorder; neuroleptic; neurotransmitter precursors; neurotransmitter synthesis; phenylalanine; plasma absorption; sex difference; tardive dyskinesia;
D O I
10.1007/s002130050958
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: An association between tardive dyskinesia (TD) and severely impaired metabolism of the large neutral amino acid (LNAA), phenylalanine (Phe) was defined in a group of mentally retarded patients. Subsequently, an altered kinetics of Phe was associated with TD in men with schizophrenia based on plasma analyses subsequent to the ingestion of a protein meal. Methods: In the present study, a standardized oral challenge of pure Phe (100 mg/kg in 170 mi orange juice) was administered to psychiatric patients of both sexes (n = 312), with and without TD after an overnight fast. Plasma LNAA levels were assayed both fasting and 2 h subsequent to the ingestion of the challenge. The extent of the increase in plasma Phe levels 2 h following a standardized challenge is determined by the sum of the kinetic processes of plasma absorption, tissue distribution, metabolism and elimination. Results: The study hypothesis, that TD would be associated with significantly higher post-challenge plasma Phe indices' of an absolute plasma Phe level and plasma Phe/LNAA ratio (a brain availability measure), was verified for the study men (n = 209), but not for the study women (n = 103). Conclusions: The demonstrated altered kinetics of Phe in men with TD indicates a greater availability of Phe to the brain in these men. We suggest that the disorder may be related to the effects of this greater availability Such effects could be the direct neurotoxic effects of Phe and its metabolites and/or the modulating effects of these compounds on the synthesis of the monoamine neurotransmitters. The fact that TD (Yes/No) group differences in postchallenge plasma Phe indices were not seen for the study women suggests the possibility of a sex difference in the biology of TD that we propose may be reflective of the young age of the study sample.
引用
收藏
页码:347 / 357
页数:11
相关论文
共 81 条
  • [61] SERUM AMINO-ACIDS, CENTRAL MONOAMINES, AND HORMONES IN DRUG-NAIVE, DRUG-FREE, AND NEUROLEPTIC-TREATED SCHIZOPHRENIC-PATIENTS AND HEALTHY-SUBJECTS
    RAO, ML
    GROSS, G
    STREBEL, B
    BRAUNIG, P
    HUBER, G
    KLOSTERKOTTER, J
    [J]. PSYCHIATRY RESEARCH, 1990, 34 (03) : 243 - 257
  • [62] RICHARDSON MA, 1982, AM J PSYCHIAT, V139, P341
  • [63] RICHARDSON MA, 1986, PSYCHOPHARMACOL BULL, V22, P243
  • [64] RICHARDSON MA, 1989, PSYCHOPHARMACOL BULL, V25, P47
  • [65] RICHARDSON MA, 1989, BIOL PSYCHIAT, V25, pA161
  • [66] DELAYED PLASMA-CLEARANCE OF PHENYLALANINE AND TYROSINE IN ELDERLY MEN
    RUDMAN, D
    ABBASI, AA
    CHAUDRY, F
    MATTSON, DE
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1991, 39 (01) : 33 - 38
  • [67] Effect of smoking on neuroleptics in schizophrenia
    Salokangas, RKR
    Saarijarvi, S
    Taiminen, T
    Lehto, H
    Niemi, H
    Ahola, V
    Syvalahti, E
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 23 (01) : 55 - 60
  • [68] GENDER AND THE USE OF NEUROLEPTICS IN SCHIZOPHRENIA FURTHER TESTING OF THE ESTROGEN HYPOTHESIS
    SALOKANGAS, RKR
    [J]. SCHIZOPHRENIA RESEARCH, 1995, 16 (01) : 7 - 16
  • [69] SANDYK R, 1986, NEW ENGL J MED, V314, P1257
  • [70] SARWAR G, 1991, J AM COLL NUTR, V10, P668